We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

226 hedge funds and large institutions have $931M invested in Adaptive Biotechnologies in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 82 increasing their positions, 59 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more call options, than puts

Call options by funds: $1.23M | Put options by funds: $522K

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

39% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 59

8% more funds holding

Funds holding: 209 → 226 (+17)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.69% less ownership

Funds ownership: 94.37% → 91.68% (-2.7%)

14% less capital invested

Capital invested by funds: $1.08B → $931M (-$152M)

Holders
226
Holders Change
+17
Holders Change %
+8.13%
% of All Funds
3.89%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
82
Reduced
59
Closed
25
Calls
$1.23M
Puts
$522K
Net Calls
+$704K
Net Calls Change
-$502K

Top Buyers

1
BlackRock
BlackRock
New York
+$10.3M
2
Goldman Sachs
Goldman Sachs
New York
+$5.33M
3
AAP
Aristotle Atlantic Partners
Florida
+$5.32M
4
AIM
ARK Investment Management
Florida
+$5.31M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$4.71M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$96.9M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5M
3
Charles Schwab
Charles Schwab
California
-$2.78M
4
BG
Bellevue Group
Switzerland
-$2.44M
5
Marshall Wace
Marshall Wace
United Kingdom
-$2.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$5.64M +$1.26M +133,991 +20%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$4.85M +$2.5M +265,593 +64%
T. Rowe Price Investment Management
28
T. Rowe Price Investment Management
Maryland
$4.78M +$6.33M +671,802 New
Deutsche Bank
29
Deutsche Bank
Germany
$4.66M +$53.2K +5,651 +0.9%
Neuberger Berman Group
30
Neuberger Berman Group
New York
$4.11M +$557K +59,103 +11%
JP Morgan Chase
31
JP Morgan Chase
New York
$3.88M -$156K -16,544 -3%
Alyeska Investment Group
32
Alyeska Investment Group
Illinois
$3.56M +$4.71M +500,000 New
CSS
33
Cubist Systematic Strategies
Connecticut
$3.43M +$1.55M +164,982 +52%
PAMS
34
Pictet Asset Management (Switzerland)
Switzerland
$3.38M +$1.68M +178,651 +60%
Renaissance Technologies
35
Renaissance Technologies
New York
$3.26M -$270K -28,700 -6%
N
36
Nuveen
North Carolina
$3.19M +$121K +12,861 +3%
Marshall Wace
37
Marshall Wace
United Kingdom
$3.08M -$2.4M -254,794 -37%
TCM
38
Tekla Capital Management
Massachusetts
$3.01M +$796K +84,559 +25%
American Century Companies
39
American Century Companies
Missouri
$2.86M +$2.07M +220,266 +121%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$2.84M +$178K +18,897 +5%
Lazard Asset Management
41
Lazard Asset Management
New York
$2.71M +$180K +19,083 +5%
ECM
42
ExodusPoint Capital Management
New York
$2.46M +$2.9M +308,252 +826%
TM
43
Triatomic Management
California
$2.18M -$228K -24,176 -7%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$2.15M +$815K +86,496 +40%
BCP
45
Berylson Capital Partners
Massachusetts
$2.06M +$942K +100,000 +53%
Thrivent Financial for Lutherans
46
Thrivent Financial for Lutherans
Minnesota
$2.05M +$130K +13,787 +5%
PCM
47
Peregrine Capital Management
Minnesota
$1.99M -$143K -15,222 -5%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.92M +$1.27M +134,810 +100%
PIM
49
Platinum Investment Management
Australia
$1.88M -$294K -31,168 -11%
Two Sigma Investments
50
Two Sigma Investments
New York
$1.86M -$384K -40,799 -14%
1
2
3 4 5

ADPT Hedge Fund Activity: Q3 2022 in Review

226 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q3 2022, worth a combined $931M — down 14% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ADPT positions and 25 closed out — a net gain of 19 holders — while 82 added to existing stakes and 59 trimmed.

The largest buyer was BlackRock, adding an estimated $10.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $96.9M.

  • 226 institutional investors held Adaptive Biotechnologies (ADPT) as of Q3 2022, up from 209 in Q2 2022.
  • Funds reported $931M of Adaptive Biotechnologies stock for Q3 2022, down 14% quarter-over-quarter.
  • 44 funds opened new Adaptive Biotechnologies positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Adaptive Biotechnologies buyer in Q3 2022 was BlackRock, an estimated $10.3M added.
  • The largest Adaptive Biotechnologies seller in Q3 2022 was T. Rowe Price Associates, an estimated $96.9M sold.

Based on aggregated 13F filings for Q3 2022.